ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
DEAD

Serial Number

87643233

Owner

SANOFI BIOTECHNOLOGY

Attorney

Karen Lim

Filing Date

Oct 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES Trademark

Serial Number: 87643233 • Registration: 5672358

ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES is a trademark filed by SANOFI BIOTECHNOLOGY on October 12, 2017. The trademark is classified under Class 41 (Education & Entertainment). The application is currently no longer active.

Owner Contact Info

SANOFI BIOTECHNOLOGY (96 trademarks)

54 rue La Boétie

Entity Type: 98

Trademark Details

Filing Date

October 12, 2017

Registration Date

February 12, 2019

Published for Opposition

August 7, 2018

Cancellation Date

August 22, 2025

Goods & Services

Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 22, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 12, 2024 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2020 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 12, 2019 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Jan 5, 2019 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 5, 2019 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 5, 2019 OP.D
OPPOSITION INSTITUTED NO. 999999
Oct 19, 2018 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 5, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 7, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 7, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 18, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 3, 2018 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2018 CNSA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 23, 2018 GNFN
FINAL REFUSAL E-MAILED
May 23, 2018 GNFR
FINAL REFUSAL WRITTEN
May 23, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 3, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 14, 2018 GNRN
NON-FINAL ACTION E-MAILED
Mar 14, 2018 GNRT
NON-FINAL ACTION WRITTEN
Mar 14, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2018 CRFA
ASSIGNED TO LIE
Feb 14, 2018 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 6, 2018 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 2, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 2, 2018 GNSL
SUSPENSION LETTER WRITTEN
Feb 2, 2018 CNSL
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 2, 2018 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 29, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 29, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 29, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 29, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 9, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 9, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 9, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 30, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 21, 2017 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2017 NWOS
NEW APPLICATION ENTERED
Oct 16, 2017 NWAP